MX9709749A - Metodo para reducir la toxicidad de agentes quimioterapeuticos y antivirales con nucleosidos de pirimidina acilados. - Google Patents
Metodo para reducir la toxicidad de agentes quimioterapeuticos y antivirales con nucleosidos de pirimidina acilados.Info
- Publication number
- MX9709749A MX9709749A MX9709749A MX9709749A MX9709749A MX 9709749 A MX9709749 A MX 9709749A MX 9709749 A MX9709749 A MX 9709749A MX 9709749 A MX9709749 A MX 9709749A MX 9709749 A MX9709749 A MX 9709749A
- Authority
- MX
- Mexico
- Prior art keywords
- methods
- chemotherapeutic
- antiviral agents
- pyrimidine nucleosides
- reducing toxicity
- Prior art date
Links
- 239000002246 antineoplastic agent Substances 0.000 title abstract 2
- 239000003443 antiviral agent Substances 0.000 title abstract 2
- 238000000034 method Methods 0.000 title abstract 2
- 239000002718 pyrimidine nucleoside Substances 0.000 title abstract 2
- 150000003230 pyrimidines Chemical class 0.000 title abstract 2
- 230000001988 toxicity Effects 0.000 title abstract 2
- 231100000419 toxicity Toxicity 0.000 title abstract 2
- 230000000973 chemotherapeutic effect Effects 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 2
- 241001465754 Metazoa Species 0.000 abstract 1
- 230000000118 anti-neoplastic effect Effects 0.000 abstract 1
- 230000000840 anti-viral effect Effects 0.000 abstract 1
- 238000002512 chemotherapy Methods 0.000 abstract 1
- 229940127089 cytotoxic agent Drugs 0.000 abstract 1
- 210000000777 hematopoietic system Anatomy 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
La presente invencion se refiere a compuestos, composiciones y métodos para el tratamiento y prevencion de la toxicidad debida a agentes quimioterapéuticos y agentes antivirales. La invencion describe derivados acilados de nucleosidos de pirimidina no metilados. Estos compuestos son capaces de atenuar el daño al sistema hematopoyético en animales que reciben quimioterapia antiviral o antineoplástica.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US61006795A | 1995-06-07 | 1995-06-07 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX9709749A true MX9709749A (es) | 1998-03-31 |
Family
ID=39427919
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX9709749A MX9709749A (es) | 1995-06-07 | 1997-12-05 | Metodo para reducir la toxicidad de agentes quimioterapeuticos y antivirales con nucleosidos de pirimidina acilados. |
Country Status (1)
| Country | Link |
|---|---|
| MX (1) | MX9709749A (es) |
-
1997
- 1997-12-05 MX MX9709749A patent/MX9709749A/es active IP Right Grant
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GR3036749T3 (en) | Treatment of chemotherapeutic agent and antiviral agent toxicity with acylated pyrimidine nucleosides. | |
| MX9706231A (es) | Derivados de 2-aminobenzazapina. | |
| MY108638A (en) | Antiviral nucleoside combination. | |
| EP2011499A3 (en) | Pyrrolo[2,3d]Pyrimidine compositions and their use | |
| AU7776891A (en) | 5-benzyl barbiturate derivatives | |
| AU6081294A (en) | Treatment of chemotherapeutic agent and antiviral agent toxicity with acylated pyrimidine nucleosides | |
| PH30931A (en) | 7-(Sustituted)-8-(substituted)-9-Äsubstituted glycyl) amido!-6-demethyl-6-deoxytetracyclines. | |
| ZA921911B (en) | 2,4-diaminoquinazoline derivatives for enhancing anti-tumor activity. | |
| ZA200007222B (en) | Glycopeptide derivatives and pharmaceutical compositions containing the same. | |
| AU4461293A (en) | 7-(substituted)-9-{(substituted glycyl)amido}-6-demethyl-6- deoxytetracyclines | |
| EP0211354A3 (en) | Nucleosides and their use as antineoplastic agents | |
| NO20020931L (no) | Pyrrolo[2,3-d]pyrimidin-nukleosid-analoger | |
| IL107449A0 (en) | Compositions and methods for reducing toxicity and increasing the efficacy of drugs | |
| BG102647A (en) | Acyclic nucleoside derivatives | |
| MX9800945A (es) | Uso de griseofulvina para inhibir el crecimiento de canceres. | |
| NZ313790A (en) | Nucleoside derivatives, being esters of 1-beta-d-arabinofuranosylcytosine, in treating tumours and lymphomas | |
| EP0599514A3 (en) | Pyranoquinoline derivatives as inhibitors of cell proliferation. | |
| CA2166692A1 (en) | Novel 9-n-bicyclic nucleoside agents useful as selective inhibitors of proinflammatory cytokines | |
| AU7881398A (en) | Pyrimidine nucleotide precursors for treatment of systemic inflammation and inflammatory hepatitis | |
| MX9709749A (es) | Metodo para reducir la toxicidad de agentes quimioterapeuticos y antivirales con nucleosidos de pirimidina acilados. | |
| ES2111569T3 (es) | Inactivadores de enzimas. | |
| EP0453247A3 (en) | Anti-viral compounds | |
| IL102407A (en) | Use of acylates of non-methylated pyrimidine nucleosides in medicaments for preventing or treating undesirable side-effects in anticancer or antiviral chemotherapy and pharmaceutical compositions containing the acylates | |
| IL81508A (en) | Phytopathogenic antibiotic compositions comprising rifamycin derivatives | |
| TR199701435T1 (xx) | İnterleukin ve pirimidin nükleositlerinin kompozisyonları |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| HC | Change of company name or juridical status | ||
| FG | Grant or registration |